name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
2BBA_A_P_138_1.pdb,2BBA,16472751,1.65,P54760,,2.60.120.260,A,185,P,14,NYLFSPNGPIARAW,CCCCTTTTHHHHHC,30000330000201,138,1,1,CCCCCCCCCCCCCC,14,0,A:0;C:0;E:0;G:0;K:0;L:0;M:0;P:0;Q:0;S:0;T:0;V:0,A:0;C:0;E:0;G:0;K:0;L:0;M:0;P:0;Q:0;S:0;T:0;V:0,A:2;D:3;E:5;G:3;H:5;K:2;L:3;N:1;P:2;Q:1;R:6;S:1;T:2,A:14;C:2;D:5;E:7;F:7;G:6;H:5;I:1;K:6;L:13;M:2;N:2;P:5;Q:5;R:5;S:4;T:11;V:11;W:5;Y:7,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:5;E:6;G:2;T:23,B:2;C:17;E:66;G:3;T:35,138_1,A:2;C:2;E:2;G:2;K:2;L:5;M:1;P:1;Q:1;S:2;T:4;V:2,C:3;E:19;G:1;T:3,A:0;C:0;E:0;G:0;K:0;L:0;M:0;P:0;Q:0;S:0;T:0;V:0,C:0;E:0;G:0;T:0,96455665555678,ALA_144_A_COREBINDING;ALA_175_A_COREBINDING;CYS_173_A_COREBINDING;CYS_50_A_COREBINDING;GLN_53_A_COREBINDING;GLU_32_A_COREBINDING;GLU_48_A_COREBINDING;GLY_146_A_COREBINDING;GLY_36_A_COREBINDING;LEU_177_A_COREBINDING;LEU_34_A_COREBINDING;LEU_37_A_COREBINDING;LEU_84_A_COREBINDING;LEU_89_A_COREBINDING;LYS_138_A_COREBINDING;LYS_147_A_COREBINDING;MET_174_A_COREBINDING;PRO_90_A_COREBINDING;SER_35_A_COREBINDING;SER_88_A_COREBINDING;THR_136_A_COREBINDING;THR_145_A_COREBINDING;THR_46_A_COREBINDING;THR_82_A_COREBINDING;VAL_148_A_COREBINDING;VAL_49_A_COREBINDING,TNYLFSPNGPIARAW,-1,0.432432432432432,,99999999999999,ASN_1_P_C;TYR_2_P_C;LEU_3_P_C;PHE_4_P_C;SER_5_P_C;PRO_6_P_C;ASN_7_P_C;GLY_8_P_C;PRO_9_P_C;ILE_10_P_C;ALA_11_P_C;ARG_12_P_C;ALA_13_P_C;TRP_14_P_C,"CRYSTAL STRUCTURE AND THERMODYNAMIC CHARACTERIZATION OF THE EPHB4 2 RECEPTOR IN COMPLEX WITH AN EPHRINB2 ANTAGONIST PEPTIDE REVEALS THE 3 DETERMINANTS FOR RECEPTOR SPECIFICITY KEYWDS AUTHOR"
2QBX_A_P_138_3.pdb,2QBX,17897949,2.30,P29323,,2.60.120.260,A,176,P,9,SNEWIQPRL,CTTTTCCCC,101103024,138,3,1,CCCCCCCCC,9,0,C:0;D:0;E:0;F:0;G:0;I:0;K:0;M:0;N:0;Q:0;R:0;S:0;V:0,C:0;D:0;E:0;F:0;G:0;I:0;K:0;M:0;N:0;Q:0;R:0;S:0;V:0,A:1;D:2;E:5;F:2;G:3;H:1;K:1;N:2;P:3;R:4;S:7;T:4,A:8;C:2;D:6;E:7;F:8;G:7;H:2;I:6;K:4;L:7;M:5;N:6;P:4;Q:3;R:6;S:6;T:8;V:12;W:5;Y:8,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:6;E:3;G:2;T:24,B:2;C:19;E:74;G:3;T:22,138_3,C:2;D:1;E:1;F:1;G:1;I:1;K:1;M:2;N:1;Q:1;R:2;S:4;V:3,C:2;E:12;G:1;T:6,C:0;D:0;E:0;F:0;G:0;I:0;K:0;M:0;N:0;Q:0;R:0;S:0;V:0,C:0;E:0;G:0;T:0,433334407,ARG_136_A_COREBINDING;ARG_76_A_COREBINDING;ASN_44_A_COREBINDING;ASP_77_A_COREBINDING;CYS_165_A_COREBINDING;CYS_43_A_COREBINDING;GLN_41_A_COREBINDING;GLU_25_A_COREBINDING;GLY_135_A_COREBINDING;ILE_81_A_COREBINDING;LYS_139_A_COREBINDING;MET_138_A_COREBINDING;MET_166_A_COREBINDING;PHE_46_A_COREBINDING;SER_167_A_COREBINDING;SER_22_A_COREBINDING;SER_74_A_COREBINDING;SER_80_A_COREBINDING;VAL_137_A_COREBINDING;VAL_45_A_COREBINDING;VAL_75_A_COREBINDING,SNEWIQPRLPQH,-1,0.508968058968059,,999999999,SER_1_P_C;ASN_2_P_C;GLU_3_P_C;TRP_4_P_C;ILE_5_P_C;GLN_6_P_C;PRO_7_P_C;ARG_8_P_C;LEU_9_P_C,"EPHB2SNEW ANTAGONISTIC PEPTIDE COMPLEX"
4W50_D_H_138_2.pdb,4W50,25268696,2.42,P54764,PF01404,2.60.120.260,D,176,H,12,APYCVYRGSWSC,CTTTEETTTEEC,321010202033,138,2,1,CCCCCCCCCCCC,12,0,A:0;C:0;E:0;G:0;I:0;K:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;V:0,A:0;C:0;E:0;G:0;I:0;K:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;V:0,A:1;D:2;E:4;F:1;G:5;K:5;L:1;M:2;N:4;P:2;Q:2;R:2;S:3;V:1,A:5;C:2;D:10;E:10;F:7;G:6;I:10;K:4;L:8;N:5;P:2;Q:4;R:7;S:7;T:10;V:11;W:4;Y:7,C:0;E:0;T:0,C:0;E:0;T:0,C:15;E:2;G:3;T:15,B:2;C:18;E:73;G:6;T:20,138_2,A:1;C:2;E:1;G:1;I:3;K:1;L:3;M:2;N:1;P:1;Q:1;R:2;T:1;V:2,C:5;E:11;T:6,A:0;C:0;E:0;G:0;I:0;K:0;L:0;M:0;N:0;P:0;Q:0;R:0;T:0;V:0,C:0;E:0;T:0,767766666667,ALA_166_D_COREBINDING;ARG_135_D_COREBINDING;ARG_79_D_COREBINDING;ASN_47_D_COREBINDING;CYS_164_D_COREBINDING;CYS_46_D_COREBINDING;GLN_44_D_COREBINDING;GLU_28_D_COREBINDING;GLY_25_D_COREBINDING;ILE_132_D_COREBINDING;ILE_165_D_COREBINDING;ILE_32_D_COREBINDING;LEU_139_D_COREBINDING;LEU_78_D_COREBINDING;LEU_84_D_COREBINDING;LYS_138_D_COREBINDING;MET_137_D_COREBINDING;MET_49_D_COREBINDING;PRO_85_D_COREBINDING;THR_77_D_COREBINDING;VAL_30_D_COREBINDING;VAL_48_D_COREBINDING,APYCVYRGSWSC,-1,0.514373464373464,,999999999999,ALA_1_H_C;PRO_2_H_C;TYR_3_H_C;CYS_4_H_C;VAL_5_H_C;TYR_6_H_C;ARG_7_H_C;GLY_8_H_C;SER_9_H_C;TRP_10_H_C;SER_11_H_C;CYS_12_H_C,"STRUCTURE OF THE EPHA4 LBD IN COMPLEX WITH PEPTIDE"
